Gavin Wood
2020
In 2020, Gavin Wood earned a total compensation of $1.6M as Chief Financial Officer at Adaptimmune Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $165,358 |
|---|---|
| Option Awards | $990,268 |
| Salary | $334,058 |
| Other | $73,073 |
| Total | $1,562,758 |
Wood received $990.3K in option awards, accounting for 63% of the total pay in 2020.
Wood also received $165.4K in non-equity incentive plan, $334.1K in salary and $73.1K in other compensation.
Rankings
In 2020, Gavin Wood's compensation ranked 6,659th out of 13,090 executives tracked by ExecPay. In other words, Wood earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,659 out of 13,090 | 49th |
Division Manufacturing | 2,766 out of 5,621 | 51st |
Major group Chemicals And Allied Products | 1,116 out of 2,254 | 51st |
Industry group Drugs | 965 out of 1,954 | 51st |
Industry Biological Products, Except Diagnostic Substances | 228 out of 411 | 45th |
Source: SEC filing on April 21, 2022.
Wood's colleagues
We found four more compensation records of executives who worked with Gavin Wood at Adaptimmune Therapeutics in 2020.